A Delphi Study to Detect Deficiencies and Propose Actions in Real Life Treatment of Neovascular Age-Related Macular Degeneration

Purpose. Spanish retina specialists were surveyed in order to propose actions to decrease deficiencies in real-life neovascular age macular degeneration treatment (nv-AMD). Methods. One hundred experts, members of the Spanish Vitreoretinal Society (SERV), were invited to complete an online survey of...

Full description

Saved in:
Bibliographic Details
Main Authors: Alfredo García-Layana, Luis Arias, Marta S. Figueroa, Javier Araiz, José María Ruiz-Moreno, José García-Arumí, Francisco Gómez-Ulla, María Isabel López-Gálvez, Francisco Cabrera-López, José Manuel García-Campos, Jordi Monés, Enrique Cervera, Felix Armadá, Roberto Gallego-Pinazo, Antonio Piñero-Bustamante, Miguel Angel Serrano-Garcia
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2014/595132
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850105316414324736
author Alfredo García-Layana
Luis Arias
Marta S. Figueroa
Javier Araiz
José María Ruiz-Moreno
José García-Arumí
Francisco Gómez-Ulla
María Isabel López-Gálvez
Francisco Cabrera-López
José Manuel García-Campos
Jordi Monés
Enrique Cervera
Felix Armadá
Roberto Gallego-Pinazo
Antonio Piñero-Bustamante
Miguel Angel Serrano-Garcia
author_facet Alfredo García-Layana
Luis Arias
Marta S. Figueroa
Javier Araiz
José María Ruiz-Moreno
José García-Arumí
Francisco Gómez-Ulla
María Isabel López-Gálvez
Francisco Cabrera-López
José Manuel García-Campos
Jordi Monés
Enrique Cervera
Felix Armadá
Roberto Gallego-Pinazo
Antonio Piñero-Bustamante
Miguel Angel Serrano-Garcia
author_sort Alfredo García-Layana
collection DOAJ
description Purpose. Spanish retina specialists were surveyed in order to propose actions to decrease deficiencies in real-life neovascular age macular degeneration treatment (nv-AMD). Methods. One hundred experts, members of the Spanish Vitreoretinal Society (SERV), were invited to complete an online survey of 52 statements about nv-AMD management with a modified Delphi methodology. Four rounds were performed using a 5-point Linkert scale. Recommendations were developed after analyzing the differences between the results and the SERV guidelines recommendations. Results. Eighty-seven specialists completed all the Delphi rounds. Once major potential deficiencies in real-life nv-AMD treatment were identified, 15 recommendations were developed with a high level of agreement. Consensus statements to reduce the burden of the disease included the use of treat and extend regimen and to reduce the amount of diagnostic tests during the loading phase and training technical staff to perform these tests and reduce the time between relapse detection and reinjection, as well as establishing patient referral protocols to outside general ophthalmology clinics. Conclusion. The level of agreement with the final recommendations for nv-AMD treatment among Spanish retinal specialist was high indicating that some actions could be applied in order to reduce the deficiencies in real-life nv-AMD treatment.
format Article
id doaj-art-3cefdc55df7f4d84a67f15116c0251ec
institution OA Journals
issn 2090-004X
2090-0058
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-3cefdc55df7f4d84a67f15116c0251ec2025-08-20T02:39:08ZengWileyJournal of Ophthalmology2090-004X2090-00582014-01-01201410.1155/2014/595132595132A Delphi Study to Detect Deficiencies and Propose Actions in Real Life Treatment of Neovascular Age-Related Macular DegenerationAlfredo García-Layana0Luis Arias1Marta S. Figueroa2Javier Araiz3José María Ruiz-Moreno4José García-Arumí5Francisco Gómez-Ulla6María Isabel López-Gálvez7Francisco Cabrera-López8José Manuel García-Campos9Jordi Monés10Enrique Cervera11Felix Armadá12Roberto Gallego-Pinazo13Antonio Piñero-Bustamante14Miguel Angel Serrano-Garcia15Clínica Universidad de Navarra, Avenida de Pío XII 36, 31008 Pamplona, SpainHospital de Bellvitge, C/Feixa Llargasn, L’Hospitalet de Llobregat, 08907 Barcelona, SpainHospital Universitario Ramon y Cajal, Carretera de Colmenar km 9, 28034 Madrid, SpainHospital de San Eloy, Avenida Antonio Miranda 5, 48902 Baracaldo, SpainHospital Universitario de Albacete, Avenida de Almansa, s/n, 02006 Albacete, SpainHospital VallD’Hebron, Passeig de la Valld’Hebron 119-129, 08035 Barcelona, SpainInstituto Oftalmológico Gómez-Ulla, Calle Maruja Mallo 3, 15706 Santiago de Compostela, SpainIOBA, Hospital Clínico Universitario de Valladolid, Paseo de Belén 17, 47011 Valladolid, SpainComplejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria, Avenida Marítima del Sur, s/n, 35016 Las Palmas de Gran Canaria, SpainHospital Universitario Virgen de la Victoria, Campus de Teatinos, s/n, 29010 Málaga, SpainInstitut de la Macula i de la Retina, Carrer de Vilana 12, 08022 Barcelona, SpainHospital General de Valencia, Avenida Tres Cruces 2, 46014 Valencia, SpainHospital la Paz, Paseo de la Castellana 261, 28046 Madrid, SpainHospital la Fe, Valencia, Avenida de Fernando Abril Martorell 106, 46026 Valencia, SpainHospital Universitario de Valme, Avenida de Bellavista, s/n, 41014 Sevilla, SpainHospital Universitario Nuestra Señora de la Candelaria, Carretera del Rosario 145, 38010 Santa Cruz de Tenerife, SpainPurpose. Spanish retina specialists were surveyed in order to propose actions to decrease deficiencies in real-life neovascular age macular degeneration treatment (nv-AMD). Methods. One hundred experts, members of the Spanish Vitreoretinal Society (SERV), were invited to complete an online survey of 52 statements about nv-AMD management with a modified Delphi methodology. Four rounds were performed using a 5-point Linkert scale. Recommendations were developed after analyzing the differences between the results and the SERV guidelines recommendations. Results. Eighty-seven specialists completed all the Delphi rounds. Once major potential deficiencies in real-life nv-AMD treatment were identified, 15 recommendations were developed with a high level of agreement. Consensus statements to reduce the burden of the disease included the use of treat and extend regimen and to reduce the amount of diagnostic tests during the loading phase and training technical staff to perform these tests and reduce the time between relapse detection and reinjection, as well as establishing patient referral protocols to outside general ophthalmology clinics. Conclusion. The level of agreement with the final recommendations for nv-AMD treatment among Spanish retinal specialist was high indicating that some actions could be applied in order to reduce the deficiencies in real-life nv-AMD treatment.http://dx.doi.org/10.1155/2014/595132
spellingShingle Alfredo García-Layana
Luis Arias
Marta S. Figueroa
Javier Araiz
José María Ruiz-Moreno
José García-Arumí
Francisco Gómez-Ulla
María Isabel López-Gálvez
Francisco Cabrera-López
José Manuel García-Campos
Jordi Monés
Enrique Cervera
Felix Armadá
Roberto Gallego-Pinazo
Antonio Piñero-Bustamante
Miguel Angel Serrano-Garcia
A Delphi Study to Detect Deficiencies and Propose Actions in Real Life Treatment of Neovascular Age-Related Macular Degeneration
Journal of Ophthalmology
title A Delphi Study to Detect Deficiencies and Propose Actions in Real Life Treatment of Neovascular Age-Related Macular Degeneration
title_full A Delphi Study to Detect Deficiencies and Propose Actions in Real Life Treatment of Neovascular Age-Related Macular Degeneration
title_fullStr A Delphi Study to Detect Deficiencies and Propose Actions in Real Life Treatment of Neovascular Age-Related Macular Degeneration
title_full_unstemmed A Delphi Study to Detect Deficiencies and Propose Actions in Real Life Treatment of Neovascular Age-Related Macular Degeneration
title_short A Delphi Study to Detect Deficiencies and Propose Actions in Real Life Treatment of Neovascular Age-Related Macular Degeneration
title_sort delphi study to detect deficiencies and propose actions in real life treatment of neovascular age related macular degeneration
url http://dx.doi.org/10.1155/2014/595132
work_keys_str_mv AT alfredogarcialayana adelphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT luisarias adelphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT martasfigueroa adelphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT javieraraiz adelphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT josemariaruizmoreno adelphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT josegarciaarumi adelphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT franciscogomezulla adelphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT mariaisabellopezgalvez adelphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT franciscocabreralopez adelphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT josemanuelgarciacampos adelphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT jordimones adelphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT enriquecervera adelphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT felixarmada adelphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT robertogallegopinazo adelphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT antoniopinerobustamante adelphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT miguelangelserranogarcia adelphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT alfredogarcialayana delphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT luisarias delphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT martasfigueroa delphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT javieraraiz delphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT josemariaruizmoreno delphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT josegarciaarumi delphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT franciscogomezulla delphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT mariaisabellopezgalvez delphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT franciscocabreralopez delphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT josemanuelgarciacampos delphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT jordimones delphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT enriquecervera delphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT felixarmada delphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT robertogallegopinazo delphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT antoniopinerobustamante delphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration
AT miguelangelserranogarcia delphistudytodetectdeficienciesandproposeactionsinreallifetreatmentofneovascularagerelatedmaculardegeneration